The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

Gilead Sciences ( GILD) increased its growth forecast for the year on strong third quarter results, marking a shift away from ...

Despite a mission to become a dominant cancer drug player, Gilead Sciences has as of late been locked in on its ...

for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. Raltegravir Tablets USP, 600 mg are indicated ...

Results from a new study might pave the way for a longer-acting version ... The most widely used form of PrEP is a daily HIV ...

For years, a preventive treatment that can significantly decrease the risk of contracting HIV has been available in Nova ...

Studies from around the world consistently find that the number of new HIV cases falls when this is ... the sharing of ...

as it can significantly reduce new infections of HIV. 2 However, ADR and transmitted drug resistance (TDR) are possible given the encouragement to begin ART early. An increased number of countries ...

A sea sponge in the Caribbean was responsible for the first antiretroviral treatment for HIV. The venom of a lizard found in ...

Contraceptive pills increased women's risk by 73 per ... Tuberculosis Disease Intensifies HIV Antibody Response in People With HIV May 9, 2023 — New research found that people living with ...

The government has confirmed it has set aside £11.8bn to compensate victims of the infected blood scandal. More than 30,000 ...

Since the first reported case of HIV in the U.S. 43 years ago, ending HIV epidemic is possible with new medicine that may ensure long, healthy lives and prevention.